Nodal Marginal Zone Lymphoma: Impersonalized Medicine
Importantly, other lymphomas that share many characteristics with NMZL, such as lymphoplasmacytic lymphoma, demonstrate impressive results with alternative therapies that employ agents such as the proteasome inhibitor bortezomib. …
See all stories on this topic »